Oncology & Cancer

Bright future ahead for antibody cancer therapy

Antibodies, once touted as the "magic bullets" of cancer care, are now fulfilling that promise and more advances are on the way, say cancer researchers at the Georgetown Lombardi Comprehensive Cancer Center

Other

AMP opposes exclusive licensing of NIH proteomics patent

The Association for Molecular Pathology (AMP) opposed the National Institutes of Health (NIH) proposal to exclusively license the subject matter of a cancer-related proteonomics patent application filed by the Agency. AMP's ...

Oncology & Cancer

PI3K/mTOR pathway proteins tied to poor prognosis in breast cancer

Four proteins involved in translation, the final step of general protein production, are associated with poor prognosis in hormone-receptor-positive breast cancer when they are dysregulated, researchers reported at the AACR ...

Oncology & Cancer

How loss of single gene fuels deadly childhood brain cancer

Atypical teratoid rhabdoid tumors (ATRT) are a rare, fast-growing form of brain cancer that usually strikes children three years and younger, though they can occur in older children and adults. There are multiple treatments, ...

page 20 from 40